Italy’s based multinational Recordati announced the acquisition of 100% of Italchimici S.p.A., an Italian pharmaceutical company with operational headquarters in Milan. The value of the transaction is approx. € 130 million and will be funded from existing liquidity. The signing and closing of the transaction took place at the same time.

Italchimici, with over 40 years of history and € 46 million revenues in 2015, is a consolidated firm in the Italian pharmaceutical market with well-known products in the gastroenterological and respiratory areas, including pharmaceutical products, food supplements and medical devices.